Analysis of urinary 8-isoprostane as an oxidative stress biomarker by stable isotope dilution using automated online in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 112, Issue , 2015, Pages 36-42

  Mizuno, Keisuke ^a   Kataoka, Hiroyuki ^a  

^a SHUJITSU UNIVERSITY   (Japan)

Author keywords

8 Isoprostane; Automated sample preparation; In tube solid phase microextraction; Liquid chromatography tandem mass spectrometry; Oxidative stress biomarker

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; BUFFER; CREATININE; STABLE ISOTOPE; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIOXIDANT; PROSTAGLANDIN F2 ALPHA;

ARTICLE; AUTOMATED ONLINE IN TUBE SOLID PHASE MICROEXTRACTION; AUTOMATION; CREATININE URINE LEVEL; DESORPTION; ELECTROSPRAY MASS SPECTROMETRY; FLOW INJECTION ANALYSIS; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MEASUREMENT ACCURACY; NORMAL HUMAN; ONLINE SYSTEM; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS; ANALOGS AND DERIVATIVES; CHEMISTRY; PHYSIOLOGY; PROCEDURES; URINE;

ANTIOXIDANTS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; DINOPROST; HUMANS; MALE; ONLINE SYSTEMS; OXIDATIVE STRESS; SOLID PHASE MICROEXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84929660189     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2015.04.020     Document Type: Article

References (40)

1. Azad N., Rojanasakul Y., Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health B: Crit. Rev. 2008, 11:1-15.
2. Padurariu M., Ciobica A., Lefter R., Serban I.L., Stefanescu C., Chirita R. The oxidative stress hypothesis in Alzheimer's disease. Psychiatr. Danub. 2013, 25:401-409.
3. Yu J.H., Kim H. Oxidative stress and cytokines in the pathogenesis of pancreatic cancer. J. Cancer Prev. 2014, 19:97-102.
4. Csányi G., Miller F.J. Oxidative stress in cardiovascular disease. Int. J. Mol. Sci. 2014, 15:6002-6008.
5. Valavanidis A., Vlachogianni T., Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health 2009, 6:445-462.
6. Aseervatham G.S., Sivasudha T., Jeyadevi R., Arul Ananth D. Environmental factors and unhealthy lifestyle influence oxidative stress in humans - an overview. Environ. Sci. Pollut. Res. Int. 2013, 20:4356-4369.
7. Il'yasova D., Scarbrough P., Spasojevic I. Urinary biomarkers of oxidative status. Clin. Chim. Acta 2012, 413:1446-1453.
8. Shroff A., Mamalis A., Jagdeo J. Oxidative stress and skin fibrosis. Curr. Pathobiol. Rep. 2014, 2:257-267.
9. Reverri E.J., Morrissey B.M., Cross C.E., Steinberg F.M. Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis. Free Radic. Biol. Med. 2014, 76C:261-277.
10. Siwek M., Sowa-Kućma M., Dudek D., Styczeń K., Szewczyk B., Kotarska K., Misztakk P., Pilc A., Wolak M., Nowak G. Oxidative stress markers in affective disorders. Pharmacol. Rep. 2013, 65:1558-1571.
11. Schulze P.C., Lee R.T. Oxidative stress and atherosclerosis. Curr. Atheroscler. Rep. 2005, 7:242-248.
12. Rodrigo R., Libuy M., Feliú F., Hasson D. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis. Markers 2013, 35:773-790.
13. Segal B.M., Thomas W., Zhu X., Diebes A., McElvain G., Baechler E., Gross M. Oxidative stress and fatigue in systemic lupus erythematosus. Lupus 2012, 21:984-992.
14. Kaviarasan S., Muniandy S., Qvist R., Ismail I.S. F2-isoprostanes as novel biomarkers for type 2 diabetes: a review. J. Clin. Biochem. Nutr. 2009, 45:1-8.
15. Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim. Biophys. Acta 2014, 1840:809-817.
16. Morrow J.D. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr. Pharm. Des. 2006, 12:895-902.
17. Abou-Raya A., el-Hallous D., Fayed H. 8-Isoprostaglandin F2α: a potential index of lipid peroxidation in systemic lupus erythematosus. Clin. Invest. Med. 2004, 27:306-311.
18. Comporti M., Arezzini B., Signorini C., Vecchio D., Gardi C. Oxidative stress, isoprostanes and hepatic fibrosis. Histol. Histopathol. 2009, 24:893-900.
19. Rossner P., Gammon M.D., Terry M.B., Agrawal M., Zhang F.F., Teitelbaum S.L., Eng S.M., Gaudet M.M., Neugut A.I., Santella R.M. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:639-644.
20. Brys M., Morel A., Forma E., Krzeslak A., Wilkosz J., Rozanski W., Olas B. Relationship of urinary isoprostanes to prostate cancer occurrence. Mol. Cell Biochem. 2013, 372:149-153.
21. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 2005, 25:279-286.
22. Yan W., Byrd G.D., Ogden M.W. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J. Lipid Res. 2007, 48:1607-1617.
23. Taylor A.W., Bruno R.S., Traber M.G. Women and smokers have elevated urinary F2-isoprostane metabolites: a novel extraction and LC-MS methodology. Lipids 2008, 43:925-936.
24. Tomey K.M., Sowers M.R., Li X., McConnell D.S., Crawford S., Gold E.B., Lasley B., Randolph J.F. Dietary fat subgroups, zinc, and vegetable components are related to urine F2α-isoprostane concentration, a measure of oxidative stress, in midlife women. J. Nutr. 2007, 137:2412-2419.
25. Dahl J.H., van Breemen R.B. Rapid quantitative analysis of 8-iso-prostaglandin-F2α using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method. Anal. Biochem. 2010, 404:211-216.
26. Smith K.A., Shepherd J., Wakil A., Kilpatrick E.S. A comparison of methods for the measurement of 8-isoPGF2α: a marker of oxidative stress. Ann. Clin. Biochem. 2011, 48:147-154.
27. Klawitter J., Haschke M., Shokati T., Klawitter J., Christians U. Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Commun. Mass Spectrom. 2011, 25:463-468.
28. Morales C.R., Terry E.S., Zackert W.E., Montine T.J., Morrow J.D. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F2t-isoprostane (8-iso-PGF2α) by a stable isotope dilution mass spectrometric assay. Clin. Chim. Acta 2001, 314:93-99.
29. Saenger A.K., Laha T.J., Edenfield M.J., Sadrzadeh S.M. Quantification of urinary 8-iso-PGF2α using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels. Clin. Biochem. 2007, 40:1297-1304.
30. Bastani N.E., Gundersen T.E., Blomhoff R. Determination of 8-epi PGF2α concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2885-2890.
31. Teng Y.H., Wang C.W., Liao Y.T., Yang M.W., Liu T.Y. Quantification of urinary 8-iso-prostaglandin F2α using liquid chromatography-tandem mass spectrometry during cardiac valve surgery. J. Clin. Lab. Anal. 2010, 24:237-245.
32. Cavalca V., Minardi F., Scurati S., Guidugli F., Squellerio I., Veglia F., Dainese L., Guarino A., Tremoli E., Caruso D. Simultaneous quantification of 8-iso-prostaglandin-F2α and 11-dehydro thromboxane B2 in human urine by liquid chromatography-tandem mass spectrometry. Anal. Biochem. 2010, 397:168-174.
33. Prasain J.K., Arabshahi A., Taub P.R., Sweeney S., Moore R., Sharer J.D., Barnes S. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2013, 913-914:161-168.
34. Kataoka H., Inoue R., Yagi K., Saito K. Determination of nicotine, cotinine, and related alkaloids in human urine and saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2009, 49:108-114.
35. Saito K., Yagi K., Ishizaki A., Kataoka H. Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:727-733.
36. Kataoka H., Inoue T., Ikekita N., Saito K. Development of exposure assessment method based on the analysis of urinary heterocyclic amines as biomarkers by on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2014, 406:2171-2178.
37. Kataoka H. Automated sample preparation using in-tube solid-phase microextraction and its application: a review. Anal. Bioanal. Chem. 2002, 373:31-45.
38. Kataoka H. Recent developments and applications of microextraction techniques in drug analysis. Anal. Bioanal. Chem. 2010, 396:339-364.
39. Sánchez-Moreno C., Cano M.P., de Ancos B., Plaza L., Olmedilla B., Granado F., Martín A. Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans. Am. J. Clin. Nutr. 2003, 78:454-460.
40. Chan K.H., Ho S.P., Yeung S.C., So W.H., Cho C.H., Koo M.W., Lam W.K., Ip M.S., Man R.Y., Mak J.C. Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir. Med. 2009, 103:1746-1754.